Immunoglobulin Market Report

Immunoglobulin Market Report, By Product (IgG, IgA, IgM, IgE, IgD), Mode of Delivery (Intravenous, Subcutaneous), Application (Chronic Inflammatory Demyelinating Polyneuropathy (CIDP), Guillain?Barre Syndrome, Hypogammaglobulinemia, Idiopathic Thrombocytopenic Purpura (ITP), Immunodeficiency Disease, Inflammatory Myopathies, Multifocal Motor Neuropathy, Myasthenia Gravis, Specific Antibody Deficiency) and Geography – Global Market Share, Trend Analysis & Forecast , 2019 - 2028

Report Code : 10580 | Publish Date : Upcoming | Industry : Biotechnology | Geography : Global


  • Report Description
  • Summary

Immunoglobulin is a protein which is produce by plasma cells and lymphocytes. It plays an essential role for destroying the foreign substance such bacteria, destroying. The immune globulin products are ideally generated from plasma collected from the large number of screened donors. Besides the immunoglobulin products is used replacement therapy for immunodeficiency patient or as immunomodulatory therapy for autoimmune and alloimmune disorders. The products are majorly provided by intravenous, subcutaneous mode of delivery. The market is expected to witness growing demand due to new product launches in the market. 

Immunoglobulin Market Report Outlook

The key factor contributing in the global immunoglobulin market are rising in prevalence of immunodeficiency diseases. In addition, it is majorly observed in children. Also, increase in adoption of immunoglobulin is propel the demand for the immunoglobulin market. Besides growing research and development activities for advanced product innovation has boosted the growth of the market. 

COVID 19 IMPACT ON IMMUNOGLOBULIN MARKET REPORT

The exclusive COVID 19 impact analysis report by Axiom MRC provides a 3600 analysis of micro and macro-economic factors on the immunoglobulin market. In addition, complete analysis of changes on the MDO films market expenditure, economic and international policies on supply and demand side. The report also studies the impact of pandemic on global economies, international trade, business investments, GDP and marketing strategies of key players present in the market.


IMMUNOGLOBULIN MARKET SEGMENTAL OVERVIEW

The immunoglobulin market is segmented based on product, mode of delivery, application and geography. 

IMMUNOGLOBULIN MARKET BY PRODUCT

The immunoglobulin is available in market according different product including IgG, IgA, IgM, IgE, IgD. IgG is widely used product in the immunoglobulin market owing to its potential to eliminate the infectious agent further the product can be ideally used for patient once a week or every two weeks. This key factor of product is expected to drive the growth of product segment thereby fueling the growth of the immunoglobulin market. 

IMMUNOGLOBULIN MARKET BY MODE OF DELIVERY 

The immunoglobulin is given by different mode of delivery like intravenous, subcutaneous. Intravenous further includes 5% Concentration, 10% Concentration and subcutaneous is bifurcated to 16.5% Concentration, 20% Concentration. The subcutaneous is expected to lead in the market growing at the fastest pace. The growth is due to increasing number of product launches and adoption for the subcutaneous in the market. For instance, Grifols has announced the launch of latest immunoglobulin innovation, XEMBIFY which is immune globulin subcutaneous human- klhw. Also, it is the company first 20% subcutaneous immunoglobulin therapy for the treatment of patient 2 years of age and older with primary immunodeficiency (PI) 

IMMUNOGLOBULIN MARKET BY APPLICATION 

The immunoglobulin market finds application in chronic inflammatory demyelinating polyneuropathy (cidp), guillain?barre syndrome, hypogammaglobulinemia, idiopathic thrombocytopenic purpura (itp), immunodeficiency disease, inflammatory myopathies, multifocal motor neuropathy, myasthenia gravis, and specific antibody deficiency.  Hypogammaglobulinemia is anticipated to gain market in the global immunoglobulin market. The growth of the segment is due to rising deficiency of selective IgG among population. Further, growing prevalence of the hypogammaglobulinemia disorder worldwide has fueled the growth of market. 

IMMUNOGLOBULIN MARKET BY GEOGRAPHY

Geographically immunoglobulin market is studied for the following region North America, Europe, Asia Pacific and RoW. North America is projected to lead in the global Immunoglobulin market owing to increasing demand from hospital and clinics for the treatment of primary immunodeficiency disease in patient.  Besides growing adoption and approval for the immunoglobulin has further boosted the growth of market. On the other hand, Asia Pacific is expected to witness the growth at highest rate during the estimated timeframe.  The growing presence of manufacturing in the region is propelling growth by increasing expansion, new product launches in the region is also propelling the market growth. 

IMMUNOGLOBULIN MARKET KEY PLAYER

The key players in immunoglobulin market are ADMA Biologics, Inc, Baxter international Inc., Bayer Healthcare, Bio Products Laboratory, Biotest AG, China Biologics Products, Inc, CSL Ltd., Evolve Biologics Inc, GigaGen, Inc., Grifols S.A, Johnson & Johnson (Omrix Biopharmaceuticals, Inc), Kedrion Biopharma Inc., LFB group, Octapharma AG, Sanquin Plasma Products B.V., Shanghai RAAS Blood Products Co., Ltd, Shire (Baxalta) and Takeda Pharmaceutical Company Limited among others.

The report analyses the global immunoglobulin market based on product, mode of delivery, application and geography. The immunoglobulin is available in market according different product including IgG, IgA, IgM, IgE, IgD. The immunoglobulin is given by different mode of delivery like intravenous, subcutaneous. The immunoglobulin market finds application in chronic inflammatory demyelinating polyneuropathy (cidp), guillain?barre syndrome, hypogammaglobulinemia, idiopathic thrombocytopenic purpura (itp), immunodeficiency disease, inflammatory myopathies, multifocal motor neuropathy, myasthenia gravis, and specific antibody deficiency. Geographically immunoglobulin market is studied for the following region North America, Europe, Asia Pacific and RoW. 

The key players in immunoglobulin market are ADMA Biologics, Inc, Baxter international Inc., Bayer Healthcare, Bio Products Laboratory, Biotest AG, China Biologics Products, Inc, CSL Ltd., Evolve Biologics Inc, GigaGen, Inc., Grifols S.A, Johnson & Johnson (Omrix Biopharmaceuticals, Inc), Kedrion Biopharma Inc., LFB group, Octapharma AG, Sanquin Plasma Products B.V., Shanghai RAAS Blood Products Co., Ltd, Shire (Baxalta) and Takeda Pharmaceutical Company Limited among others. 

Why to buy this report:

  • The report offers changing market dynamics in immunoglobulin, presenting historical, current and projected market size in terms of value (USD Million)
  • The research study provides an in-depth analysis of the industry value chain focusing on the peer and parent markets of immunoglobulin
  • It presents a comprehensive assessment of geographical regions exhibiting promising growth, potential and niche segments, and a neutral perspective on the immunoglobulin performance
  • The report also offers strategic recommendations in key business segments based on the market estimations and competitive landscape, mapping the key common trends of immunoglobulin